Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

BMS Bolsters China Compliance In Wake Of SEC Fine

This article was originally published in PharmAsia News

Executive Summary

Following an investigation under the US Foreign Corrupt Practices Act violations, Bristol-Myers Squibb has been fined for improper business activities in China, which has been strengthening policies on drug price monitoring and to control kickbacks to doctors. The US firm says the matter has been resolved through a number of steps to improve practices and compliance.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register